Systemic sclerosis (SSc) is an uncommon, complex, multisystemic disorder, characterized by severe fibrosis of the skin and various internal organs. As in other collagenoses, the etiology of SSc is unknown and the exact mechanisms involved in the pathogenesis are not well understood. For the clinical and pathogenetic manifestations, however, the following key processes have been identified: 1) excessive accumulation of collagen and other components of the extracellular matrix; 2) early morphological changes in small blood vessels; and 3) alterations in the cellular and humoral immune response resulting in the production of disease-specific antibodies. Currently, it remains unclear how these processes interact, to cause a chronic and progressive fibrotic disease. Continued research, has however yielded substantial insight into the molecular understanding of several basic mechanisms, suggesting novel therapeutic targets for the future.
机构:
Univ Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA 94143 USAUniv Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA 94143 USA
Katsumoto, Tamiko R.
Whitfield, Michael L.
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA 94143 USA
Whitfield, Michael L.
Connolly, M. Kari
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA 94143 USA
Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USAUniv Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA 94143 USA
Connolly, M. Kari
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6,
2011,
6
: 509
-
537